# Ascentage Pharma Group International: Form 6-K, filed Aug 3, 2026

- Company: [Ascentage Pharma Group International](/companies/aapg.md) (CIK 2023311)
- Form: 6-K
- Filed: 2026-08-03
- Accepted by EDGAR: Aug 3, 2026, 07:30 ET
- Period: 2026-08-03
- Accession: 0001213900-26-084247
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2023311/000121390026084247/ea0300203-6k_ascentage.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2023311/000121390026084247/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2023311/000121390026084247/ea0300203-6k_ascentage.htm

Filed Aug 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-084247. Last ingested by Listed: Nov 5, 2026, 12:38 ET. No prices; not investment advice.